These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29190085)

  • 1. High-Confidence Protein-Ligand Complex Modeling by NMR-Guided Docking Enables Early Hit Optimization.
    Proudfoot A; Bussiere DE; Lingel A
    J Am Chem Soc; 2017 Dec; 139(49):17824-17833. PubMed ID: 29190085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of ligand binding modes in weak protein-ligand complexes using sparse NMR data.
    Mohanty B; Williams ML; Doak BC; Vazirani M; Ilyichova O; Wang G; Bermel W; Simpson JS; Chalmers DK; King GF; Mobli M; Scanlon MJ
    J Biomol NMR; 2016 Nov; 66(3):195-208. PubMed ID: 27778134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge-guided docking: accurate prospective prediction of bound configurations of novel ligands using Surflex-Dock.
    Cleves AE; Jain AN
    J Comput Aided Mol Des; 2015 Jun; 29(6):485-509. PubMed ID: 25940276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of protein-ligand docking with simulated chemical shift perturbations.
    Ten Brink T; Aguirre C; Exner TE; Krimm I
    J Chem Inf Model; 2015 Feb; 55(2):275-83. PubMed ID: 25357133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steering protein-ligand docking with quantitative NMR chemical shift perturbations.
    González-Ruiz D; Gohlke H
    J Chem Inf Model; 2009 Oct; 49(10):2260-71. PubMed ID: 19795907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accounting for conformational variability in protein-ligand docking with NMR-guided rescoring.
    Skjærven L; Codutti L; Angelini A; Grimaldi M; Latek D; Monecke P; Dreyer MK; Carlomagno T
    J Am Chem Soc; 2013 Apr; 135(15):5819-27. PubMed ID: 23565800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR Data-Driven Docking of HDM2-Inhibitor Complexes.
    Fradera X; Reutershan MH; Machacek MR; Trotter BW; McCoy MA
    Chembiochem; 2022 Mar; 23(6):e202100570. PubMed ID: 35104390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process of Fragment-Based Lead Discovery-A Perspective from NMR.
    Ma R; Wang P; Wu J; Ruan K
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico fragment-based drug design with SEED.
    Marchand JR; Caflisch A
    Eur J Med Chem; 2018 Aug; 156():907-917. PubMed ID: 30064119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of (19)F-NMR in Fragment-Based Drug Discovery.
    Norton RS; Leung EW; Chandrashekaran IR; MacRaild CA
    Molecules; 2016 Jul; 21(7):. PubMed ID: 27438818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the use of intermolecular NOE constraints for obtaining docked structures of protein-ligand complexes.
    Gradwell MJ; Feeney J
    J Biomol NMR; 1996 Jan; 7(1):48-58. PubMed ID: 8720831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions.
    Deng Z; Chuaqui C; Singh J
    J Med Chem; 2004 Jan; 47(2):337-44. PubMed ID: 14711306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HybridDock: A Hybrid Protein-Ligand Docking Protocol Integrating Protein- and Ligand-Based Approaches.
    Huang SY; Li M; Wang J; Pan Y
    J Chem Inf Model; 2016 Jun; 56(6):1078-87. PubMed ID: 26317502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR studies of ligand binding.
    Nitsche C; Otting G
    Curr Opin Struct Biol; 2018 Feb; 48():16-22. PubMed ID: 29017071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR characterization of weak interactions between RhoGDI2 and fragment screening hits.
    Liu J; Gao J; Li F; Ma R; Wei Q; Wang A; Wu J; Ruan K
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3061-3070. PubMed ID: 27721047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CORCEMA refinement of the bound ligand conformation within the protein binding pocket in reversibly forming weak complexes using STD-NMR intensities.
    Jayalakshmi V; Rama Krishna N
    J Magn Reson; 2004 May; 168(1):36-45. PubMed ID: 15082247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid protein-ligand costructures using chemical shift perturbations.
    Stark J; Powers R
    J Am Chem Soc; 2008 Jan; 130(2):535-45. PubMed ID: 18088118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR-Based Determination of the 3D Structure of the Ligand-Protein Interaction Site without Protein Resonance Assignment.
    Orts J; Wälti MA; Marsh M; Vera L; Gossert AD; Güntert P; Riek R
    J Am Chem Soc; 2016 Apr; 138(13):4393-400. PubMed ID: 26943491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of spin diffusion methods for the determination of protein-ligand complex structural ensembles.
    Pilger J; Mazur A; Monecke P; Schreuder H; Elshorst B; Bartoschek S; Langer T; Schiffer A; Krimm I; Wegstroth M; Lee D; Hessler G; Wendt KU; Becker S; Griesinger C
    Angew Chem Int Ed Engl; 2015 May; 54(22):6511-5. PubMed ID: 25877959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.